New Molecular Mechanism Involved in Cellular Senescence That Modulates Inflammation and Response to Cancer Immunotherapy

Wistar scientists discovered a novel pathway that enables detection of DNA in the cytoplasm and triggers inflammation and cellular senescence. This pathway may be modulated during senescence-inducing chemotherapy to affect cancer cell response to...
19-Feb-2020 10:55 AM EST Add to Favorites

Wistar Joins Global Effort to Expedite Coronavirus Vaccine Development for Outbreak Originating in China

Wistar announces today that they are part of a team to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV) that has infected hundreds in China and other countries, including the U.S., and resulted in numerous deaths to...
23-Jan-2020 1:50 PM EST Add to Favorites

The Wistar Institute Received Nearly $2.5M in Philanthropic Support

In the past six months, scientists at The Wistar Institute received funding from private foundations totaling $2,418,000 that will fuel new discoveries in cancer, immunology and infectious diseases.
19-Dec-2019 4:20 PM EST Add to Favorites

New Therapeutic Strategy for Chemotherapy Resistance in Ovarian Cancer

A Wistar study demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of stem-like chemoresistant cells following cisplatin treatment.
19-Dec-2019 10:40 AM EST Add to Favorites

Microscopic World Comes Alive During Nikon Small World Exhibit

See cellular images as distinct as abstract art, minerals appear as future urban landscapes, single-celled organisms of the microscopic netherworld, and much more from the 2019 Nikon Small World competition of photomicrography.
17-Dec-2019 3:55 PM EST Add to Favorites

International Collaboration for Scientific Training Launched Between The Wistar Institute and Leiden University Medical Center in the Netherlands

Wistar and Leiden University Medical Center (LUMC) formalized a memorandum of understanding between the two institutions to explore a postdoctoral training exchange program in immunology, cancer research and vaccine biology. The Wistar-Schoemaker...
15-Nov-2019 1:40 PM EST Add to Favorites

Synthetic DNA Technology Applied as a Novel Strategy for Delivery of Anti-HIV Antibodies

Wistar scientists applied synthetic DNA-based technology to drive in vivo production of broadly neutralizing anti-HIV antibodies in small and large-animal models, providing proof of concept for a simple and effective next generation approach to HIV...
8-Nov-2019 12:50 PM EST Add to Favorites

Wistar Institute Researcher Awarded American Cancer Society Research Professorship

The American Cancer Society has awarded a Research Professorship to Wistar's Dmitry l. Gabrilovich, M.D., Ph.D. This lifelong designation, accompanied by a five-year $400,000 commitment, is the most prestigious research grant made by ACS.
22-Oct-2019 10:30 AM EDT Add to Favorites

See All News